DIPEXIUM PHARMACEUTICALS INC's ticker is DPRX and the CUSIP is 25456J104. A total of 13 filers reported holding DIPEXIUM PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $98,000 | -41.3% | 10,311 | -31.0% | 0.01% | -36.4% |
| Q4 2015 | $167,000 | -30.7% | 14,943 | -13.2% | 0.02% | -35.3% |
| Q3 2015 | $241,000 | +8.6% | 17,220 | -1.1% | 0.03% | +25.9% |
| Q2 2015 | $222,000 | +36.2% | 17,420 | +45.7% | 0.03% | +42.1% |
| Q1 2015 | $163,000 | +26.4% | 11,956 | +5.7% | 0.02% | +11.8% |
| Q4 2014 | $129,000 | +27.7% | 11,306 | +13.1% | 0.02% | -10.5% |
| Q1 2014 | $101,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lone Star Value Management LLC | 95,000 | $1,330,000 | 2.54% |
| Timpani Capital Management LLC | 134,716 | $1,886,000 | 0.76% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 981,100 | $13,735,000 | 0.66% |
| 1492 Capital Management LLC | 38,000 | $532,000 | 0.38% |
| Broadfin Capital, LLC | 465,978 | $6,524,000 | 0.36% |
| Tourbillon Capital Partners, L.P. | 785,615 | $10,999,000 | 0.29% |
| ARDSLEY ADVISORY PARTNERS LP | 45,000 | $630,000 | 0.15% |
| 683 Capital Management, LLC | 70,000 | $980,000 | 0.14% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,043 | $253,000 | 0.12% |
| FALCON POINT CAPITAL, LLC | 22,570 | $316,000 | 0.11% |